J
JANUX THERAPEUTICS INC
NASDAQ: JANX (Janux Therapeutics, Inc.)
Kemas kini terakhir: semalam, 1:21AM14.22
0.07 (0.49%)
| Penutupan Terdahulu | 14.15 |
| Buka | 14.33 |
| Jumlah Dagangan | 1,037,233 |
| Purata Dagangan (3B) | 969,740 |
| Modal Pasaran | 867,197,504 |
| Harga / Jualan (P/S) | 64.03 |
| Harga / Buku (P/B) | 0.920 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Aug 2026 |
| Margin Operasi (TTM) | -1,216.61% |
| EPS Cair (TTM) | -1.36 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -100.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 2.23% |
| Nisbah Semasa (MRQ) | 58.47 |
| Aliran Tunai Operasi (OCF TTM) | -46.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -27.01 M |
| Pulangan Atas Aset (ROA TTM) | -8.16% |
| Pulangan Atas Ekuiti (ROE TTM) | -9.32% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Janux Therapeutics, Inc. | Menaik | Menurun |
AISkor Stockmoo
0.6
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | 1.5 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -2.0 |
| Purata | 0.60 |
|
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 6.69% |
| % Dimiliki oleh Institusi | 113.78% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Prosight Management, Lp | 31 Mar 2026 | 3,550,000 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BARRETT RONALD W | 13.66 | - | 5,500 | 75,130 |
| CAPPS VICKIE L | 13.66 | - | 5,500 | 75,130 |
| DOBMEIER ERIC | 13.66 | - | 5,500 | 75,130 |
| HERNDAY NATASHA | 13.66 | - | 5,500 | 75,130 |
| KUNG WINSTON | 13.66 | - | 5,500 | 75,130 |
| RA CAPITAL MANAGEMENT, L.P. | 13.66 | - | 5,500 | 75,130 |
| SIMSON JAKE | 13.66 | - | 5,500 | 75,130 |
| Jumlah Keseluruhan Kuantiti Bersih | 38,500 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 525,910 | |||
| Purata Pembelian Keseluruhan ($) | 13.66 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| BARRETT RONALD W | Pengarah | 11 Jun 2026 | Diperolehi (+) | 5,500 | 13.66 | 75,130 |
| DOBMEIER ERIC | Pengarah | 11 Jun 2026 | Diperolehi (+) | 5,500 | 13.66 | 75,130 |
| CAPPS VICKIE L | Pengarah | 11 Jun 2026 | Diperolehi (+) | 5,500 | 13.66 | 75,130 |
| KUNG WINSTON | Pengarah | 11 Jun 2026 | Diperolehi (+) | 5,500 | 13.66 | 75,130 |
| HERNDAY NATASHA | Pengarah | 11 Jun 2026 | Diperolehi (+) | 5,500 | 13.66 | 75,130 |
| SIMSON JAKE | Pengarah | 11 Jun 2026 | Diperolehi (+) | 5,500 | 13.66 | 75,130 |
| RA CAPITAL MANAGEMENT, L.P. | Pengarah | 11 Jun 2026 | Diperolehi (+) | 5,500 | 13.66 | 75,130 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |